Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/
Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.
BACK TO LIST

Laboratory Report

Patient
Name: Johnson, Stanley
DOB: 05-MAR-1941 (Age: 85)
Gender: male
Address:
289 Smith garden
TN1 Terencebury (United Kingdom)
ID: 7188-531997-1 (ECI)
Report
Date: 28-AUG-2021
Laboratory
dr Ample, Ex
Laboratoire Central Européenne
Boulevard du Jardin Botanique 32
1000 Brussels (Belgium)
Requested by
Evelina Children's Hospital
SE1 7 London (United Kingdom)
Specimen
Collected: 28-AUG-2021

Chemistry

Test 28-AUG-2021 Reference Range Unit
Hemoglobin A1c/Hemoglobin.total in Blood 5.8 4.8 - 5.9 %
Glucose [Mass/volume] in Blood 166.8 H 70 - 100 mg/dL
Urea nitrogen [Mass/volume] in Blood 19.1 7 - 20 mg/dL
Creatinine [Mass/volume] in Blood 0.9 0.7 - 1.3 mg/dL
Calcium [Mass/volume] in Blood 9.2 8.5 - 10.5 mg/dL
Sodium [Moles/volume] in Blood 136.0 135 - 145 mmol/L
Potassium [Moles/volume] in Blood 4.0 3.5 - 5.1 mmol/L
Chloride [Moles/volume] in Blood 103.0 98 - 110 mmol/L
Carbon dioxide, total [Moles/volume] in Blood 27.0 22 - 29 mmol/L
Cholesterol [Mass/volume] in Serum or Plasma 253.1 H 125 - 200 mg/dL
Triglyceride [Mass/volume] in Serum or Plasma 418.9 H 0 - 149 mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay 131.7 H 0 - 100 mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma 37.6 L 40 - 60 mg/dL
Microalbumin/Creatinine [Mass Ratio] in Urine 11.6 0 - 30 mg/g

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
The patient shows significant hyperglycemia with elevated fasting glucose, but HbA1c is at the upper end of normal, suggesting possible recent glucose dysregulation. Lipid profile is markedly abnormal with high total cholesterol, LDL, triglycerides, and low HDL, indicating increased cardiovascular risk. Renal function and electrolytes are within normal limits, and there is no evidence of microalbuminuria. Recommend further evaluation and management of dyslipidemia and glucose control.